Temu Lawak (Curcuma xanthorrhiza)

Temu lawak (Curcuma xanthorrhiza) contains xanthorrhizol and curcumin as primary bioactive compounds that exhibit hepatoprotective and antimicrobial properties. These compounds modulate inflammatory pathways and oxidative stress responses, though clinical evidence remains limited to animal studies.

Origin & History

Temu Lawak (Curcuma xanthorrhiza Roxb.) is a rhizomatous plant from the Zingiberaceae family, native to and widely cultivated in Indonesia. The medicinal rhizome is traditionally extracted through maceration processes to obtain bioactive sesquiterpenoids and curcuminoids.

Historical & Cultural Context

Curcuma xanthorrhiza has been extensively utilized in Indonesia as a medicinal and nutritional plant since ancient times, serving as a key ingredient in jamu, the traditional Indonesian herbal medicine system. Historically used as a general tonic and for treating gastrointestinal disorders, liver conditions, and inflammatory ailments.

Health Benefits

• Antibacterial activity demonstrated in vitro with MIC values of 6.25-50.00 mg/ml against E. coli, S. aureus, and other pathogens (laboratory evidence only)
• Hepatoprotective and antioxidant effects shown in animal models against CCl₄-induced liver damage (no human trials available)
• Potential cancer prevention properties identified through computational molecular docking studies (preliminary computational evidence only)
• Traditional use for gastrointestinal disorders including dysentery, constipation, and appetite loss (traditional evidence, no clinical validation)
• Anti-inflammatory applications for arthritis and rheumatism based on traditional Indonesian medicine (no clinical trials provided)

How It Works

Xanthorrhizol and curcumin in temu lawak inhibit pro-inflammatory cytokines like TNF-α and IL-6 while activating antioxidant enzymes including glutathione peroxidase and catalase. These compounds modulate NF-κB signaling pathways and enhance hepatic detoxification processes. The antimicrobial activity occurs through disruption of bacterial cell wall synthesis and membrane integrity.

Scientific Research

The available research consists primarily of in vitro and computational studies rather than human clinical trials. Recent 2025 research investigated anticancer potential using network pharmacology and molecular docking approaches, while antibacterial studies demonstrated activity in laboratory settings. No specific human RCTs or meta-analyses with PMIDs were provided in the research dossier.

Clinical Summary

Current evidence is limited to in vitro and animal studies, with no published human clinical trials available. Laboratory studies demonstrate antimicrobial activity with MIC values of 6.25-50.00 mg/ml against E. coli and S. aureus. Animal models show hepatoprotective effects against CCl₄-induced liver damage, but human efficacy and optimal dosing remain unestablished. More rigorous clinical research is needed to validate traditional uses.

Nutritional Profile

Temu Lawak (Curcuma xanthorrhiza) rhizome contains approximately 48-59% starch (dry weight basis) as primary macronutrient, making it a notable carbohydrate source. Crude fiber content ranges from 2.6-4.8% dry weight. Protein content is relatively low at 6.6-8.2% dry weight. Fat content approximately 1.6-3.2% dry weight, predominantly unsaturated fatty acids. Primary bioactive compounds: curcuminoids (1.6-2.2% dry weight), predominantly xanthorrhizol (a bisabolane-type sesquiterpenoid unique to this species, 0.8-1.5% in essential oil), curcumin (0.3-0.9%), demethoxycurcumin, and bisdemethoxycurcumin. Essential oil content ranges 3.0-6.0% dry weight, containing ar-turmerone, α-turmerone, β-turmerone, and zingiberene. Mineral profile includes potassium (approximately 1,525 mg/100g dry weight), calcium (273 mg/100g), phosphorus (125 mg/100g), magnesium (47 mg/100g), iron (4.7 mg/100g), and zinc (1.2 mg/100g). Vitamin content includes niacin (~3.9 mg/100g), ascorbic acid (~5.0 mg/100g fresh weight), and trace amounts of B-complex vitamins. Bioavailability note: curcuminoids exhibit poor oral bioavailability (<1% absorption) due to rapid metabolism and low aqueous solubility; xanthorrhizol shows relatively better absorption than curcumin in preliminary studies; co-administration with piperine or lipid carriers significantly enhances curcuminoid bioavailability by up to 20-fold. Starch fraction shows moderate glycemic response with resistant starch component estimated at 8-12%.

Preparation & Dosage

No clinically studied human dosage ranges are available in the research. Laboratory antibacterial studies used concentrations of 6.25-50.00 mg/ml, but these cannot be translated to human doses. Traditional jamu formulations exist but specific dosages are not documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Ginger, Black Pepper Extract, Milk Thistle, Turmeric

Safety & Interactions

Safety data in humans is limited, though traditional use suggests general tolerability in healthy adults. May interact with anticoagulant medications due to curcumin content, potentially enhancing bleeding risk. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with gallstones or bile duct obstruction should consult healthcare providers before use due to potential cholagogue effects.